The World Health Organization has added lifesaving interleukin-6 receptor blockers to its list of treatments for COVID-19 as the pandemic continues to accelerate across the world.
The WHO says the medicines worked particularly well when used alongside corticosteroids, which were recommended by the WHO in September 2020.
WHO Director-General Tedros Adhanom Ghebreyesus in a statement says these drugs offer hope for patients and families who are suffering from the devastating impact of severe and critical COVID-19.
The WHO says the trials showed that in severely ill patients, administering the drugs resulted in 15 fewer deaths per 1,000 patients.
The World Health Organization has added lifesaving interleukin-6 receptor blockers to its list of treatments for COVID-19 as the pandemic continues to accelerate across the world.
The WHO says the medicines worked particularly well when used alongside corticosteroids, which were recommended by the WHO in September 2020.
WHO Director-General Tedros Adhanom Ghebreyesus in a statement says these drugs offer hope for patients and families who are suffering from the devastating impact of severe and critical COVID-19.
The WHO says the trials showed that in severely ill patients, administering the drugs resulted in 15 fewer deaths per 1,000 patients.
read more
read less
